NEW YORK, NY--(Marketwired - Mar 19, 2014) - IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

NEW YORK, NY--(Marketwired - Mar 24, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

Joint pain took over Jim Cole’s life so much so that he decided to try Enbrel, a drug that he said ended up causing him more pain than relief. He stopped playing golf, his favorite past time, and didn ...

The Company licensed the technology for Australia & New Zealand for a one-time payment offer $700,000 and 12 1/2% Royalty Stream NEW YORK--(BUSINESS WIRE)-- Intellicell Biosciences, Inc. (OTCQB: SVFC) ...

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences Inc. (“IntelliCell” or the “Company”) today announced that its previously announced merger with Media Exchange Group, Inc. (“MEG”) (OTCQB: CWLCD) has ...

NEW YORK, NY--(Marketwired - August 21, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal ...

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that it has been successful in manufacturing stromal vascular cells from Non-Living adipose ...

Partners will investigate stromal vascular fraction cells, the basis of IntelliCell’s product. IntelliCell BioSciences inked a sponsored research agreement with the Institute for Cell Engineering and ...

The serial number for this application is 86104962. The international trademark goods and services class code for this trademark application is 042. As submitted by the applicant, this trademark ...

NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“Intellicell”) or the (“Company”), Intellicell has licensed its ...